Company news
PureTech Health PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
PRTC Acquires Clinical Stage Asset for Lymphedema
July 17, 2019
Potential US Listing of PureTech Health on Nasdaq
July 11, 2019
PRTC Immuno-Oncology Programme Granted US Patent
July 9, 2019
PRTC's Karuna closes IPO, gross proceeds $102.6M
July 3, 2019
First Patient in Vedanta Food Allergy Study
July 1, 2019
PureTech's Karuna successfully lists on NASDAQ
June 28, 2019
PureTech Announces New Corporate HQ/Internal Labs
June 20, 2019
Follica Positive Interim Data & Plans for Pivotal
June 13, 2019
PRTC's Karuna Files Public S1 for NASDAQ IPO
June 3, 2019
PRTC to Present at Jefferies US Conference
May 30, 2019
Vor Publishes POC Study in Scientific Journal
May 29, 2019
Vedanta Presents Expanded Data from Successful Ph1
May 21, 2019
Promising Gelesis Data in Chronic Constipation
May 20, 2019
Gelesis & Vedanta Data at Digestive Disease Week
May 14, 2019
Vedanta Grows Series C Financing to $45.5 Million
May 13, 2019
Vedanta Prevails in Important EU Patent Opposition
May 7, 2019
PRTC's Karuna Files IPO Registration Statement
April 26, 2019
Gelesis Gets $10.6M Grant to Support Manufacturing
April 25, 2019
Boehringer Ingelheim & PRTC Immuno-oncology Collab
April 17, 2019
Gelesis Receives FDA Clearance for First Product
April 15, 2019
Akili Makes CFO & General Counsel Appointments
April 11, 2019
Gelesis Presents Data on Effects of High-Fat Diet
April 11, 2019
Sonde Completes $16M Series A Financing Round
April 11, 2019
PRTC Presents Immuno-Oncology Programmes at AACR
April 2, 2019
Karuna expands Series B financing to $80 million
April 1, 2019
Gelesis Preclinical Data on Restoring Gut Barrier
March 25, 2019
Gelesis New Clinical Data on Impact of Gelesis100
March 25, 2019
Gelesis to Present at Endocrine Society Annual Mtg
March 21, 2019
Karuna Announces $68 Million Series B Financing
March 18, 2019
Akili & Shionogi Deal in Taiwan/Japan $20M upfront
March 7, 2019
Karuna Appoints Chief Financial Officer
March 5, 2019
PRTC to Present at Two US Investor Conferences
February 21, 2019
Vor Raises $42M to Advance Leukaemia Treatment
February 14, 2019
Alivio Partners to Advance Non-opioid Pain Therapy
January 28, 2019
Vedanta Immuno-oncology Candidate Published
January 23, 2019
Vedanta Biosciences Raise $27M Series C Financing
December 24, 2018
Vedanta Initiates Phase 2 Study for Lead Candidate
December 17, 2018
Vedanta & BMS Immuno-Oncology Collaboration
December 10, 2018
Vor Granted First-in-class Immuno-oncology Patent
November 28, 2018
Janssen/Vedanta Phase 1 in IBD & $12M Milestone
November 27, 2018
Full Gelesis Data Published in the Journal Obesity
November 13, 2018
PRTC to Present at Jefferies 2018 in London
November 7, 2018
Vedanta Presents Data on Immuno-Oncology Candidate
November 6, 2018
Gelesis to Present Full Data for Lead Candidate
November 5, 2018
Karuna Adds Sage Therapeutics CEO to Board
October 17, 2018
resTORbio Announces Additional Positive Ph 2b Data
October 16, 2018
Karuna Initiates Phase 2 Study in Schizophrenia
October 15, 2018
Vedanta Announces Successful Ph1 Clinical Results
October 4, 2018
Brain Lymphatics Published in Nature Neuroscience
September 17, 2018
Akili Exclusively Licenses New Digital Technology
September 12, 2018
Calls
The 5 newest of 6 calls. Every call is listed under its year.
- PureTech Health (LSE:PRTC) Q2 2026 Earnings Call
Sep 22, 2026
Transcript - PureTech Health (LSE:PRTC) Q4 2025 Earnings Call
Apr 29, 2026
Transcript - PureTech Health (LSE:PRTC) Q2 2025 Earnings Call
Aug 28, 2025
Transcript - PureTech Health (LSE:PRTC) Q4 2024 Earnings Call
Apr 30, 2025
Transcript - PureTech Health (LSE:PRTC) Q2 2024 Earnings Call
Aug 28, 2024
Transcript
Decks
The 5 newest of 7 decks. Every deck is listed under its year.
- Investor Presentation (October 2026)
Investor deck · 39 slides · October 2026
- H1 2026 Earnings Presentation
Earnings · 23 slides · Sep 22, 2026
- Investor Presentation (April 2026)
Investor deck · 21 slides · Apr 1, 2026
- Investor Presentation (March 2026)
Investor deck · 37 slides · March 2026
- Technical Presentation (March 2026)
Technical · 14 slides · March 2026